Dutasteride vs Finasteride: Why One Outperforms the Other Genetically
Clinical Summary & Executive TakeawayFast Read
Evidence Grade
FDA Approved / Phase 3 International Clinical Data
Target Pathway
Dual Type 1 and Type 2 5 Alpha Reductase Inhibition (>90% serum, >50% scalp DHT suppression)
Safety & Tolerance Note:
Higher systemic DHT suppression than finasteride; monitor for hormonal adverse events.
Practical Patient Verdict:
Clinically superior to finasteride in scalp hair count, particularly when finasteride has plateaued. Requires physician prescription and baseline monitoring.
New research suggests that dutasteride outperforms finasteride in treating certain genetic forms of hair loss, and understanding the genetic mechanisms behind this disparity is crucial for developing more effective treatments. in clinical practice, I've seen firsthand the impact of these medications on patients, and the latest findings have significant implications for the future of hair restoration.
Sign in to like, save, or comment.
References & Clinical Data
- Hair follicle stem cells and their niche , Rompolas P, Greco V (Journal of Investigative Dermatology, 2014)
- Androgenetic alopecia: pathogenesis and potential for therapy , Blume-Peytavi U, et al. (British Journal of Dermatology, 2011)
- Wnt-dependent de novo hair follicle regeneration in adult mouse skin , Ito M, et al. (Nature, 2007)
- Exosome-based therapy in hair follicle regeneration , Rajendran RL, et al. (Cells, 2020)